Bacillus anthracis protective antigen
US7355027B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jun 15, 2005 |
| Grant date | Apr 8, 2008 |
| Priority date | — |
| Expiry date | Jun 15, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A polynucleotide sequence is provided, comprising: a nucleic acid sequence having at least 75% identity to SEQ ID NO: 1, wherein said nucleic acid sequence encodes recombinant Bacillus anthracis Protective Antigen (rPA); or a fragment of said nucleic acid sequence wherein said fragment encodes a fragment of recombinant Bacillus anthracis Protective Antigen (rPA).Also provided are expression vectors and host cells comprising the polynucleotide sequence of the invention, and methods for producing rPA or a fragment thereof.The invention further provides antigenic compositions and corresponding methods and uses for inducing an immune response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.